Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
Full name: Novartis Farmaceutica S.A de C.V.
Previous name(s): Sandoz de Mexico, S.A (1996)
Legal Form: Limited Liability Company
Operational Status: Operational
Incorporation Date: 1947
Novartis Farmaceutica S.A. de C.V., founded in 1996, is the pharmaceutical division of Novartis Group dedicated to developing, manufacturing and marketing of pharmaceuticals for human health and animal health. Novartis Group in Mexico consists of Novartis Farmaceutica (patent medicines), Sandoz(generics products), OTC (prescription drug free), CIBA Vision (supplier of contact lenses and care products), Novartis Animal Health (pharmaceutical veterinary) and Novartis vaccines and Diagnostics (vaccines andMore
|Company Tear Sheet|
|NAICS Industry Classification||✓||✕|
|Share Price information||✓||✕|
|Subsidiaries and Affiliates||✓||✕|
|Key Financial Highlights||✓||✕|
|Financial Performance Charts||✓||✕|
|Latest M&A and ECM Deals||✓||✕|
|EMIS Credit Analytics|
|EMIS Benchmark Score||✓||✕|
- or -
EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.
If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.